Samarkand Group plc (SMK)
THIS ANNOUNCEMENT, INCLUDING THE INFORMATION CONTAINED IN IT IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR FROM
THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN
DATE: 15 March 2021
Samarkand Group plc
("Samarkand", the "Company" or together with its subsidiaries the "Group")
Announcement of Publication of Prospectus
Samarkand Group plc, the cross-border eCommerce technology and retail group, is pleased to announce that following the oversubscribed fundraising announcement published on Friday 12 March in connection with its initial public offering, its
The Prospectus relates to the admission of the Company's ordinary shares to trading on the Apex segment of the Aquis Stock Exchange ("Admission").
The Prospectus will shortly be available on the Company's website at www.samarkand.global , subject to certain access restrictions. The Prospectus has also been submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism from Wednesday, 17 March 2021.
Admission and the commencement of unconditional dealings is expected to take place at 8.00 am (
For more information, please contact:
About Samarkand Group plc
Samarkand is a cross-border eCommerce technology and retail group focusing on connecting Western Brands with
The Company's current customer base comprises leading European brands such as 111SKIN, Shay & Blue, Omorovicza, ICONIC London, Philip Kingsley, Temple Spa, Zita West Products and Planet Organic. Samarkand has also successfully grown its own brand, Probio7, acquired in December 2017.
Founded in 2016, Samarkand is headquartered in
For further information please visit https://www.samarkand.global/
|EQS News ID:||1175724|
|End of Announcement||EQS News Service|